Los Angeles Capital Management LLC Biocryst Pharmaceuticals Inc Transaction History
Los Angeles Capital Management LLC
- $22.3 Billion
- Q1 2025
A detailed history of Los Angeles Capital Management LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 101,378 shares of BCRX stock, worth $888,071. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101,378
Previous 101,188
0.19%
Holding current value
$888,071
Previous $760,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding BCRX
# of Institutions
294Shares Held
177MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$190 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$175 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$78.2 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$76.2 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$68.4 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.63B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...